FDA Approves Glycerol Phenylbutyrate Application by Lupin
The FDA has approved the application ANDA207694 for Glycerol Phenylbutyrate submitted by Lupin.
Therapeutic Area
Therapeutic area intelligence for Urea Cycle Disorders with 9 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.